






Since the beginning of the HIV epidemic, intravenous drug use has been directly and indirectly accountable for more than 1/3 of all cases. It has been shown that syringe exchange programs (SEPs) prevent and reduce incidence of HIV and other blood borne pathogens among IDUs. Approximately 203 SEPs are operating in 34 different states, but less than 10% of IDUs can access their services. This is of strategic public health significance due to the recent federal ban on funding for SEPs in January 2012. One response to this, in an effort to increase coverage and reduce incidence of blood borne pathogens, IDUs have spontaneously emerged as “secondary syringe exchangers” (SSEs) to disseminate sterile injection equipment in the community. Although secondary exchangers exist, minimal data exists on their effectiveness and risk for HIV and other blood borne pathogens.
A critical literature review included peer-reviewed studies on SSEs anywhere in the United States. Relevant research with regard to SSEs was accessed primarily through medical, public health, and social science databases. In order to ensure that relevant studies were included, the search terms used employed multiple synonyms for SEPs and SSEs, with no publication date restrictions. 
The studies included in the review were concentrated in two states and were subject to several different types of bias including: recall, response, interviewer, and sampling. The majority of studies found that SSEs were likely to be African American, male, unemployed, and had more extensive social interactions with other IDUs and larger networks. HIV risk-related behaviors were higher among receptive secondary exchangers versus distributive exchangers; however, both were more likely to be protected against HIV versus non-exchangers.
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Early in the HIV epidemic, it became obvious that the virus was affecting populations other than men who have sex with men (MSM); in particular, intravenous drug users. Intravenous drug users (IDUs) were being diagnosed with opportunistic infections identical to those found in MSMs. Shortly after, the same infections became apparent in the non-drug-using female sexual partners of male IDUs. This supported theories that the immunodeficiency syndrome was caused by a similar or identical agent infecting MSMs. In addition, this supported the idea that the agent was transmitted primarily through injection drug use then transmitted to the female partners sexually. Eventually, HIV was discovered as the agent and researchers established that the agent could be cultivated from injection drug equipment.()
Injection drug use is also a risk factor for the transmission of the blood borne pathogens, hepatitis C virus (HCV) and hepatitis B virus (HBV).  HCV is 10 times more infectious than HIV when comparing direct blood-to-blood contact. Research estimates that approximately one-third of HIV positive people are co-infected with HCV. Unfortunately, vaccination only exists for HBV.()
In 2011, the Centers for Disease Control (CDC) estimated that 3,648 new diagnoses of HIV were due to injection drug use in the United States. In addition, 3,961 diagnoses of AIDS were due to transmission via injection drug use. Through 2010, the cumulative estimated number of AIDS diagnoses due to injection drug use totaled 277,738 cases. At the end of 2009, prevalence of HIV in the United States was estimated at 1,148,200 persons aged 13 and older, including 18.1% of persons who were undiagnosed. The CDC estimates that approximately 50,000 people in the United States are newly diagnosed with HIV each year.() 
In the United States, it is estimated that approximately 73% of intravenous drug users are infected with HCV, around 1.5 million people.() In addition, approximately 12% of IDUs are infected with HBV.() Lifetime treatment of HIV can cost over 350,000 dollars, while Hepatitis C accrues lifetime costs between 100,000 to 300,000, more if a liver transplant is required.()
Beginning in the mid-1980’s, the National Institute on Drug Abuse (NIDA) funded a research program in response to the concurrent epidemics of drug abuse and HIV/AIDS. This program was designed to study, develop, implement, and evaluate the effectiveness of a variety of interventions to reduce behavioral risks. These studies have shown that comprehensive HIV prevention strategies are the most cost-effective and reliable interventions for preventing increasing incidence in the very diverse populations of substance users. Comprehensive prevention includes a variety of essential components: outreach, drug abuse treatment, and access to sterile injection equipment to encourage protective behavior and reduce risk of blood borne pathogens. One of the programs studied, which fit all of the comprehensive requirements of NIDA, was syringe exchange programs (SEPs) or needle exchange programs (NEPs).()
SEPs, also known as NEPs, are revered as one of the greatest public health successes in blood borne pathogens.() After an alarmingly fast spread of HIV through shared syringes among IDUs early in the 1980’s, injection drug use is the only category of transmission that has shown a steady decline, largely due to needle exchange programs.() Despite concerns and disagreements in the general population, there is widespread consensus in the medical field and in public health that NEPs reduce the amount of needles shared, save lives, do not increase drug use in individuals or the community, and bring many people into recovery.(, )
 In fact, studies have shown that SEPs satisfy all of the Bradford Hill criteria, including the six additional criteria. Hill’s criteria for causation are a group of conditions necessary to provide evidence of a causal relationship between an exposure and outcome. These conditions include: strength of association, consistency of findings, specificity of causation, temporality, biological gradient of exposures, plausibility, coherence of findings, experimentation, and the analogy of similar factors are considered. Following Hill’s logic, SEPs have shown over a 30% reduction in HIV incidence at an average cost of 0.97 cents per needle saving an average lifetime treatment cost of HIV of $350,000 per case prevented. ADDIN EN.CITE (, )
SEPs are evidence based programs based on the model of Harm Reduction. According to the Harm Reduction Coalition, harm reduction is a set of practical ideas and strategies aimed at reducing negative consequences associated with drug use. It is also a social justice movement that was built on a belief in, and respect for, the rights of people who use drugs. Harm reduction incorporates a spectrum of strategies from safer drug use, to managed use, to abstinence, to meeting drug users “where they are at”. SEPs follow these same guidelines.()
The first organized SEPs in the US were established in the late 1980’s in Tacoma, Washington; Portland, Oregon; San Francisco, California; and New York City, New York. By 2002, there were 184 programs operating illegally and legally. These programs exchanged more than 24 million syringes. Currently, a total of 203 SEPs are currently known to be operating in 34 different states, the District of Columbia, Puerto Rico, and the Indian Nations, as of August 2012 estimates.()
According to the Centers for Disease Control and Prevention, many SEPs provide a wide range of related prevention and care services that are essential to reducing the risk of acquiring and transmitting blood borne infections as well as improving overall health and quality of life. Some of these services include: HIV/AIDS, HCV, and HBV education, testing, counseling, condom distribution, referrals to drug treatment, referrals to medical and social services, case management, and distribution of other injection equipment. Other drug-related injection equipment includes: cookers, cottons, bleach, alcohol swabs, ties, ascorbic acid, biohazard containers for disposal of syringes, and Narcan (opiate blocker used for overdoses).()
SEPs operate in a variety of settings including: storefronts, vans, sidewalk tabling, health clinics, and communities or areas in which IDUs gather. They often vary in hours/days of operation. They also vary in the amount of syringes that can be exchanged or accessed and the amount of drug equipment that can be distributed.() 
This topic is of particular interest in light of recent events. On World AIDS Day last year, President Barak Obama acknowledged the success in HIV/AIDS, observing that there is “the real possibility of an AIDS-free generation”(). This possibility, however, was threatened by the reinstatement of a federal funding ban by congress on SEPs, in January 2012. Even in cities with syringe exchange programs, only roughly 10% of intravenous drug users have consistent access to clean needles.()
According to the National Association of State and Territorial AIDS Directors (NASTAD), nine states and one city applied to use 2.7 million dollars in federal HIV prevention funding to expand SEP coverage.(, ) New York State, where funding was granted after the lift of the ban in 2009, used those funds to develop in areas untouched and provide more counseling and referrals to drug treatment. 
The 21 SEPs operating at 50 sites provide over 3 million clean syringes annually.  The state health department approximates that SEPs have reduced cases of HIV transmission due to intravenous drug use from 52% of new cases in 1992 to 5.4% in 2008. The AIDS Foundation of Chicago approximates that access to sterile syringes in Illinois has reduced HIV transmission among intravenous drug users by two-thirds since 2001, saving taxpayers more than 200 million dollars in medical costs.()
Many other states have legalized SEPs, like Colorado, as public health exceptions to drug laws. Others, like New Jersey, have allowed pharmacies to sell syringes over-the-counter without prescription. However, legal barriers still exist at the state level, as in Florida, which has an estimated 96,000 injection drug users, 20% of which are infected with HIV. Florida is one of over 30 states with no clear legal authority for SEPs.()
Although research exists on the efficacy, cost-effectiveness, and community benefits, the reality is that the coverage of SEPs is low. Furthermore, in light of the recent ban on federal funding, SEPs now need to employ new techniques and interventions to aid in the reduction of blood borne pathogens. A cost-effective way of doing so would be to educate and employ IDUs to distribute sterile needles and injection equipment for the SEP in the community. However, minimal research has been done on the importance of IDUs who distribute and receive sterile needles from other IDUs in coordination with SEPs. Therefore, the purpose of this literature review is to critically analyze studies on IDUs who distribute or receive sterile needles and injection equipment from SEPs through other IDUs or “secondary syringe exchangers”. 
According to Prithwish et al., IDUs can access sterile needles legally in most states through SEPs and pharmacies. In many states, pharmacies are required to sell sterile needles without prescription. However, pharmacies do not typically accept used syringes and do not provide the same medical and social services as SEPS. In addition pharmacies may serve only a specific subsection of IDUs. SEPs continually prove to be a cheap and effective alternative to pharmaceutical purchase of sterile needles.()
Research shows that increasing the amount of sterile syringes and injection equipment and reducing the amount of infected injection equipment reduces HIV incidence.(, ) In addition, it reduces risk at the individual and community level and is cost-effective. However, as mentioned, only 10% of IDUs are covered by SEPs in the United States and pharmaceutical coverage is limited and of cost to the IDU.() With an outstanding figure of 90% of IDUs not covered by SEPs, many programs have ignored one-for-one syringe exchange policies and employed “secondary”, “satellite”, or “relay” exchangers (SSEs, SSEs, or RSEs, respectively) to distribute and increase the amount of sterile syringes and injection equipment in communities. ADDIN EN.CITE ()
SSEs collect used syringes from other IDUs, exchange them for clean needles at SEPs, and deliver or sell the clean syringes and injection equipment back to their peers. Some researchers suggest that a large percentage of IDUs, not willing to use an SEP or not in geographic proximity, receive the services of SEPs through SSEs.() 
There are several benefits to secondary exchangers. In addition to increasing the amount of sterile needles in the community, they may also clean up discarded needles in order to obtain more from an SEP and are available in times to other IDUs when SEPs cannot be accessed.() In addition, they address barriers to SEP use such as: disability, fear of police, fear of disclosure, and inability to attend SEPs during hours of operation.() Potential disadvantages are that they may charge recipients, could have non- reliable hours, and potentially distribute non-sterile syringes. ADDIN EN.CITE ()
According to Lorvick et al., many SEPs rely on secondary exchangers to reach IDU communities. This is advantageous to SEPs programmatically because it increases service area, decreases operating costs, and decreases risk of legal involvement. Disadvantages include: lack of a well-established location for IDUs, limits involvement of IDUs in the ancillary services that SEPs provide, and increases the difficulty of obtaining funding for SEPs. Of 127 SEPs surveyed in 2000, only 9% did not allow SSE because they wanted their clients to have direct access to their services.()
There are growing concerns that IDUs who obtain sterile syringes through SSE are more likely to engage in HIV-related risk behaviors versus their counterparts who access SEPs directly. However, a majority of literature that exists on SSE is limited to researching clients from one or two local SEPs. Therefore, results could be due to a particular SEP program, the individuals, or the communities.() 
2.0 	METHODOLOGY
2.1	Search Strategy
Relevant research with regard to SEPs was accessed primarily through medical, public health, and social science peer-reviewed journals. Peer-reviewed journal articles were accessed through PubMed, The University of Pittsburgh PittCat System, Google Scholar, and NCBI. A total of 4 research databases were accessed and searched for publications from 1998 to the present (2013). These specific dates were used due to the limited availability of studies on the importance of SSEs. The first study published on this topic was in 1998, therefore, providing the cut-off after a search with no limitations on publication date. 
In order to ensure that relevant studies were included, the search employed multiple terms identifying SSEs. Search terms included: “syringe exchange programs” and “secondary exchange” and “United States” or  “needle exchange programs” and “secondary exchange” and “United States” or “syringe exchange programs” and “satellite exchange” and “United States” or “needle exchange programs” and “satellite exchange” and “United States” or “syringe exchange programs” and “relay exchange” and “United States” or “needle exchange programs” and “relay exchange” and “United States”. These queries were run multiple times and in multiple combinations through all fore-mentioned databases producing a total of 47 unique studies. Studies were eligible for consideration in this review if: (a) the focus of the study was secondary exchange; (b) the prevention of any blood borne disease was included; and (c) syringe exchange programs located in the United States were the primary focus. 
To capture unpublished data on SSEs and SEPs, the North American Syringe Exchange Network (NASEN), the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA) websites, and the Centers for Disease Control (CDC) Morbidity and Mortality Weekly Report (MMWR) were monitored.
In addition, a comprehensive internet search of resources was completed in the United States. A number of relevant websites were identified and used. Primarily, governmental online resources for federal agencies dealing with drug abuse and syringe exchange programs were used.
2.2	Selection Criteria
Studies were included in critical analysis based on an extensive review. Studies were excluded if measures of efficacy of SSE in conjunction with SEPs were insufficiently described. In addition, studies were excluded if: SSEs were a minor variable in the research or if SSEs were not included in the research. The study was also excluded if it focused on vaccination, was published before 1998, focused primarily on safe-injection sites or risk factors for HIV, HCV, or HBV, examined SEPs’ testing services, focused on high dead space needles, or where not located geographically within the United States. After review, 11 studies were selected based on fore-mentioned qualifications.
2.3	Study Descriptions
In correlation with much research in the field of SSEs and prevention methods, the majority of studies were cross-sectional. Statistical relationships between SSEs and demographics, HIV risk-related behaviors, and social networks were described. Overall, 8 cross-sectional and 3 longitudinal studies (cohorts) were included in this review. 
The three main themes that existing literature focused on included: factors associated with being an SSE, drug networks and social interactions of SSEs, and HIV risk-related behaviors. One study focused on odds of seroconversion due to engaging in SSE. Therefore, the results and discussion sections were differentiated into these categories. Comprehensive descriptions of studies including: study design, study period, setting, source population, recruitment style and outcomes investigated can be found in Table 1 and Table 2. 

2.4	Study EVALUATION
The eleven studies selected for review were chosen by systematic searches described in previous sections of the methodology. Data was collected from the studies after all articles were read on three occasions for accuracy and comprehensiveness. After review, it was discovered that four major themes existed in the literature including: factors associated with being a secondary syringe exchanger, drug networks and social interactions, HIV risk-related behavior, and seroconversion. Due to the variance in the aims of the studies and outcomes, analysis was divided up into the four previously mentioned categories to ensure relevance in the results and discussion section.
After identification of the four major themes data was collected systematically from the studies through the assessment of the following factors: the conceptual framework of the study, the study design, analysis, and conclusions.() Relevant data that contributed to the strengths and weaknesses of the study were defined as: the study design, study period, source population, recruitment style, outcomes investigated, educational components, sample size, screening uptake, informed consent, and measures of association or significance. The results of data collection were consolidated and can be found in Tables 1 and 2. 
Following the consolidation of data, results were reviewed and compared between studies to identify if the conceptual framework of the study was sound in that it clearly stated the hypothesis and linked the study to existing knowledge. The study designs were evaluated and compared to analyze whether the methods were described in detail and appropriate, whether the study attempted to control for bias or acknowledged its presence in the study, and whether the authors explicitly defined the limitations of the study. The analyses of the literature reviews were compared within the predefined subtopics to ensure validity and reliability and to identify consistencies and differential associations between the measures of significance. Conclusions were compared to identify if the study had discussed all possible effects on the outcomes of the research, the hypothesis was linked to the conclusion, and if the conclusion was linked to the analysis of results and interpretations of the data.()

3.0 	RESULTS
3.1	Factors Associated with Being a Secondary Syringe Exchanger
Four studies focused on demographic factors associated with being an SSE. The studies attempted to answer the questions: why and how do IDUs engage in SSE. In general, the majority of the studies found that IDUs engage in SSE for purely financial reasons or altruistic motives, in an attempt to protect those within their drug networks from blood borne pathogens. Descriptive information on the studies described in this section can be found in Tables 1 and 2. 
Riehman et al. surveyed injection drug users at 23 SEPs in the state of California to gage what type of IDUs engage in SSE. Among the men and women included in the study, researchers found that whites were more likely to be SSEs and exchanged needles at SEPs at a higher frequency than African Americans. Among women, those reporting reuse of a syringe used by another person, were less likely to engage in SSE than those who did not share syringes (p<0.10). Those reporting distributing syringes were more likely to return syringes for others than those who did not distribute (p<0.05). Among men, those who reused syringes were less likely to be a secondary exchanger (p<0.001). However, sharing syringes with another person and sexual risk behaviors were not positively associated with syringe sharing among men. In addition, women had greater odds of engaging in distributive SSE activities than men (OR: 4.14, 0.94, respectively). ADDIN EN.CITE ()
Snead et al. surveyed 47 IDUs to provide a descriptive analysis of distributive and receptive SSEs in several counties in California in order to understand the demographics and motivations of SSEs. Of the 47, 26 were distributors and 21 were recipients. For both distributors and recipients, the demographics showed that the majority of both classifications of SSEs were male (77% and 62% respectively). In addition, the majority were African American (65%). Forty percent of the population did not complete high school and 67% were unemployed. Based on the study’s findings, distributors were motivated to help others in their community, felt good about their social roles, and were enthusiastic to participate in peer interventions. ADDIN EN.CITE ()
Valente et al., in the article Satellite Exchange in the Baltimore Needle Exchange Program, identified SSEs at the Baltimore Needle Exchange program (BNEP) to determine the odds of particular characteristics being associated with SSEs. Valente et al. found that approximately 9% of BNEP users were SSEs. In addition, the SSEs included in the study often use the needles for personal use; sell syringes, and trade syringes for drugs. SSEs tended to be older (p<0.001), male (p<0.05), and unemployed (p<0.001). Also, SSEs had higher odds of using speedballs, mixes of heroin and cocaine (p< 0.001). The study sample, although it only accounted for 10% of BNEP clients, was responsible for distributing more than 64% of needles dispersed by BNEP. In addition, SSEs had 65.5 people who returned their needles, while non-SSEs had only 7.6 (p<0.001). This outstanding difference shows that the drug networks of SSEs are much more extensive than non-SSEs and will be discussed in the next section.()
In the study, Social Context of Needle Selling in Baltimore, Maryland, Latkin et al. examined the types and frequencies of social interactions among IDUs who sell needles obtained at BNEP versus those who do not sell paraphernalia. The sample consisted of 56 needle sellers and 197 non-sellers, which were predominately African American and male (95%, 65.6% respectively), as described in the majority of other studies. In addition, needle sellers were older (57.1%), more likely to be homeless in the past six months (19.6%), live with other injectors (36.4%), and more likely to report overdoses in the past six months (60.7%). No other study reported information on overdoses. In addition, Latkin et al. found that there were no differences in socioeconomic status of sellers and non-sellers, as discovered in previously mentioned studies. Drug-related behaviors varied between sellers and non-sellers. As found in the article written by Valente et al., Satellite Exchange in the Baltimore Needle Exchange Program, sellers were more likely to inject speedballs (89.3% vs. 77.5%). ADDIN EN.CITE (, )
Huo et al. found no significant differences in demographics (gender, race/ethnicity, relationships, education, and transportation or travel time to SEPs) between primary and secondary exchangers and non-SEP users.()
Murphy et al. recruited males and females in the San Francisco Bay area who were associated with the San Francisco AIDS Prevention Project. They attempted to define barriers to syringe exchange between primary and secondary exchangers. The primary barriers associated with secondary exchangers were fear of exposure, in relation to social stigma or police. Fear of police alone was reported by 42.7% of secondary exchangers, keeping them away from the medical and social benefits of SEPs. Physical and mental illnesses were also described as barriers to participation in SEPs. In fact, 12% of secondary exchangers cited illness as a main barrier to SEP use. In addition, agoraphobia, location, and operation hours of SEPs were cited as a main barrier for secondary exchangers.() 
3.2	Drug Networks and Social Interactions
Two studies included in the literature review investigated the types and frequencies of social interactions among IDUs and the characteristics of drug networks. In the study, Direct and Indirect Acquisition of Syringes from Syringe Exchange Progammes in Baltimore, Maryland, USA, Latkin et al. assessed the factors associated with acquiring syringes from the BNEP, support networks, and risk by distributing syringes with red or gray caps to IDUs. Red and gray capped syringes were used because the majority of SEPs and pharmacies in Baltimore use orange capped needles. Only 7% of the study population reported that they obtained the red or gray syringes from the BNEP solely and 26% reported that they received the syringes through another person and had not used an SEP in the past 6 months. In addition, multivariate analysis determined that there are four factors associated with returning a red or gray syringe. Those returning the red or gray capped syringes were 3.2 times more likely to obtain the syringes from the BNEP. In order to assess the network, Latkin et al. also determined that those returning the syringes were 2.8 and 2.6 times more likely to have obtained syringes from their spouse and from friends/neighbors, respectively.() 
Latkin et al. also interviewed participants on the characteristics of their networks. They found that those returning red or gray capped needles versus those who returned syringes with orange caps or other colors had a larger network size, more drug users in their network, and high numbers of members in their network who are active users. In summation, individuals with larger networks as well as those who obtained syringes from friend or neighbors were significantly more likely to report their last syringe being red or gray.()
In the study, Social Context of Needle Selling in Baltimore, Maryland, Latkin et al. examined the types and frequencies of social interactions among IDUs, in particular, sellers and non-sellers of syringes. The sample consisted of 56 needle sellers and 197 non-sellers, which were predominately African American and male. Social interactions were more common among sellers than non-sellers. Needle sellers were more likely to give or get drugs from other IDUs (83.9% vs. 58.9%, p<0.001), use drugs with others (85.7% vs. 57.4%, p<0.001), and buy drugs with others (75% vs. 50.3%, p<0.001). ADDIN EN.CITE ()
The membership of social networks differed between sellers and non-sellers as well. Participants who sold needles had more network members than those who did not sell (2.6 vs. 1.8, p<0.01). An interesting finding was that the needle sellers had a higher number of network members with whom they had discussed HIV risk-related behaviors (p<0.05). ADDIN EN.CITE ()
3.3	HIV Risk-Related Behavior
The majority of the studies focused on whether or not SSEs had higher levels of HIV risk-related behaviors than those who did not engage in SSE. Some studies separated SSEs into primary or distributive SSEs, who attended SEPs and distributed needles to others. ADDIN EN.CITE (, ) Secondary or receptive SSEs, were those who did not attend SEPs and received sterile needles through the primary SSEs.() In addition, some incorporated educational components for primary SSEs, in order to diffuse risk reduction and HIV/AIDS education to the secondary exchangers. The majority found that secondary exchangers had higher odds of sharing unsterile needles and injection equipment, and other risky behaviors. 
Of the 901 IDUs enrolled in the study done by Huo et al., 54% reported that they always exchange needles for themselves and 25% reported both exchanging for themselves and indirectly receiving needles from others. In a multiple logistic regression analysis of IDU risk behaviors, the odds of primary exchangers and secondary/mixed exchangers were 61% and 47% lower than non-SEP users. The odds of primary and secondary/mixed users bleaching a needle previously used by another person were two times greater than their non-SEP using counterparts. However, only primary exchangers had lower odds of back loading, sharing injection equipment, and lending used needles compared to non-SEP users. Secondary/mixed users were not significantly different than non-SEP users in these areas. Finally, primary exchangers had significantly higher odds than secondary/mixed exchangers of being enrolled in a drug treatment program (p<0.05).()
In the article, Social Context of Needle Selling in Baltimore, Maryland, Latkin et al., found that HIV risk-related behaviors were more prevalent among needle sellers. In particular, sellers were more likely to lend a used syringe to others than non-sellers (35.7%, 14.7%, respectively). In addition, 70% and 64.3% of sellers reported using a cooker and a cotton after someone else, respectively (p<0.05, p<0.01). Sellers were more likely to use rinse water after someone else had used it at 50% versus 32.5% of non-sellers (p<0.05). Also, sellers were more likely to use needles or injection equipment after another person without bleaching it first than non-sellers at 25% and 11.2%, respectively. ADDIN EN.CITE () 
Lorvick et al. found that approximately 75% of their study sample, recruited at 23 SEPs in California, reported engaging in secondary syringe exchange. Within their sample, they defined users as reciprocal (gave and received), receptive (received only), and distributive (gave only). Through logistic regression, they found that reciprocal SSEs were 3.1 times more likely to engage in syringe sharing. Additionally, receptive and distributive exchangers had 4.1 and 1.2 times higher odds of engaging in syringe sharing versus those who did not engage in SSE.()
Sears et al. recruited their study sample from two different areas in San Francisco, California and created a peer-based intervention with SSEs and used the other site as a comparison group. In the total sample population, 53% indicated that they had shared a syringe, 47% reported reuse, 82% admitted to inconsistent skin cleaning, and 37% reported using another IDUs’ cotton. Among the intervention site and comparison group, they found that the odds of sharing a needle were 3.748 times greater among those in the nonintervention group. In addition, the IDUs in the non-intervention site were 2.769 times more likely to reuse a syringe and 4.825 times more likely to be inconsistent with condom use with a casual partner.() 
Shrestha et al. used barcoded syringes distributed to participants associated with the AIDS link to Intravenous Experience study (ALIVE) in Baltimore, Maryland to determine multiperson use (MPU) of syringes. Participants within the cohort study were divided into groups of primary exchangers, secondary exchangers, and primary and secondary exchangers. The total percentage of syringes associated with MPU was 52% of primary exchangers, 64% of secondary, and 28% of primary and secondary exchangers. A multivariate analysis was completed for primary-only exchangers to determine HIV risk behaviors. The return of syringes with MPU among primary exchangers was associated with reported sharing of cotton (AOR= 2.06, 95% CI), lending syringes (AOR=1.70, 95% CI), and injecting less than daily (AOR=0.64, 95% CI). ADDIN EN.CITE ()
Murphy et al. recruited males and females in the San Francisco Bay area who were associated with the San Francisco AIDS Prevention Project. They divided the study population into three categories: primary exchangers, secondary exchangers, and non-exchangers. Primary exchangers were least likely to go second on a syringe (20.7%) versus secondary exchangers (25.6%) and non-exchangers (45.0%). In addition, primary exchangers were less likely to share cookers or cottons (46.3%, 45.1%) than secondary (50%, 47.6%) and non-exchangers (65%, 52.5%). Non-exchangers were also less likely to clean their skin (49.4%) than primary (85.2%) and secondary (76.8%) exchangers.()
3.4	Seroconversion
Valente et al., in the article Needle-Exchange Participation, Effectiveness, and Policy: Syringe Relay, Gender, and the Paradox of Public Health, used barcoded needles distributed at the BNEP to track SSE activities of participants. Researchers tested all participants for HIV and determined the odds that female and male participants divided into subgroups of SSEs and non-SSEs would seroconvert. In addition, they found that the odds ratio for HIV seroconversion and SSE for those enrolled in the study was 2.73 (95% CI). This shows that those who return syringes initially acquire from the SEP by someone else were 2.73 times more likely to seroconvert over the course of the study than those who returned their own syringes. In multivariate analysis including gender, duration in study, SSEs, and non-SSEs, researchers found that duration in study and engaging in SSE were significantly associated with seroconversion. Among men, there was little difference in seroconversion between SSEs and non-SSEs (1.07, non-SSEs being the referent group). However, women engaged in SSE activities were 8.53 times more likely to seroconvert over the course of the study. ADDIN EN.CITE ()
4.0 	DISCUSSION
4.1	Factors Associated with Being a Secondary Syringe Exchanger
Two studies that sought to describe the factors and demographics associated with being an SSE found that SSEs were primarily African American, although Riehman et al. found that whites were more likely to engage in SSE and Huo et al. found no difference in race among participants. ADDIN EN.CITE (, ) The 2008 National Survey on Drug Use and Health (NSDUH) found that 35% of people reporting intravenous drug use in the past year defined themselves racially as two or more races, 18% reported being Caucasian, and only 14% reported being African American.() Therefore, this could be due to the higher proportion of African Americans enrolled in the studies or possibly suggest that African Americans are more likely to engage in SSE and should be examined in further studies.()
In addition, two studies found that SSEs were more likely to be male. ADDIN EN.CITE (, ) This could also be due to the fact that the proportion of male SSEs was higher than female SSEs, subjecting this characteristic to bias. However, this could also reflect the demographics of the general IDU population.() As reported in NSDUH, twice as many males reported intravenous drug use than women.() In addition, three studies found that SSEs were more likely to be unemployed and older. ADDIN EN.CITE (, , ) These factors are also subject to bias because those who are younger and employed may be a portion of IDUs that cannot access SEPs during operating hours and may not have been enrolled in the study. Also, an interesting finding in two of the studies was that SSEs were more likely to inject speedballs. ADDIN EN.CITE (, ) Several limitations associated with these studies include: selection, social desirability, recall bias and lack of generalizability. 
A very important factor that limits the results of some studies and complicates comparison between them is definition of secondary syringe exchangers. Four of 11 studies did not differentiate between different subclasses of secondary exchangers. ADDIN EN.CITE (, , , ) The remaining studies have emphasized the importance of differentiation. 
Those investigations have defined “primary” or “distributive” exchangers, as those who have direct contact with an SEP, as will be discussed in the section on HIV risk-related behavior. They receive the protective benefits of interaction at an SEP. The majority of participants in these studies identified as primary only, biasing results across the board. Secondary or “receptive” exchangers receive sterile needles and injection equipment from the primary exchangers but do not receive the social and medical benefits of SEP interaction.() 
With regards to social interactions and drug networks, two studies focused on defining and quantifying the importance of SSEs in IDU communities. ADDIN EN.CITE (, ) In Valente et al., researchers found that an outstanding 64% of needles were distributed by SSEs for the Baltimore Needle Exchange Program showing the importance of the SSEs in this study.() Syringe exchangers were not defined explicitly as distributive or receptive; however, the study only focused on what authors have defined as “distributive”. In addition, it was found that men and women SSEs were more likely to exchange among partners, friends, and neighbors but on average had a larger network and interactions with more IDUs than those that did not engage in SSE.()
Snead et al., completed interviews with those identified as SSEs and found that “distributing” SSEs were motivated to help others in the community, felt good about their social roles in the community, and were enthusiastic to participate in interventions. Although these results are subject to social desirability bias, this is evidence that distributing SSEs may be key stakeholders in the community and might be willing and useful for disseminating sterile needles and injection equipment. In addition, they could disseminate risk reduction and HIV/AIDS information into populations of IDUs that are unwilling or unable to access SEPs directly. ADDIN EN.CITE ()
Furthermore, it was important to identify the characteristics of secondary only exchangers. Murphy et al. cited several specific examples of why and how SSEs do not seek sterile needles and injection equipment from SEPs directly. It is clear that fear of exposure is a tremendous barrier to receptive exchangers directly accessing SEPs as well as issues of disability, hours of operation, and geographic location of SEPs.()
4.2	Drug Networks and Social Interactions
Two studies described the social networks and drug interactions of SSEs in further detail. Although both data sets were subject to social desirability, recall, and sampling bias, the results suggest that BNEP is using SSEs to effectively distribute syringes within the social networks in which they exist. This study concluded that SSE is an effective method of diffusion in the IDU community and captures populations that BNEP cannot access due to individual barriers. In addition, both studies were located in Baltimore and due to the high volume of intravenous drug use in Baltimore, especially heroin injectors, the proportion of needle selling may be much greater than other metropolitan areas. ADDIN EN.CITE (, )
Moreover, needle sellers, the term Latkin et al. used for distributive SSEs that benefit financially from SEPs, have significant roots and ties in their drug network. However, there was no data included in this study on non-injecting needle sellers, overlooking a potentially key portion of subgroup within selling. Sellers are more likely to live with other IDUs, purchase drugs with other IDUs, and are financially important to networks. They also have larger networks and IDUs with whom they share needles and injection equipment. This study evidences the importance of sellers in HIV prevention. Risk behaviors are common in the social networks of sellers and are discussed frequently. ADDIN EN.CITE ()
The implication resulting from these findings are that sellers should be educated and trained in risk reduction and HIV/AIDS. Due to their importance and standing in the community, they may be the ideal stakeholder for intervention methods. However, it is important to note that both studies occurred in Baltimore, Maryland and could be characteristic of that specific metropolitan area, that particular IDU community, or unique individuals. ADDIN EN.CITE (, ) In addition, recruitment was sampled through convenience, meaning that these characteristics could be attributable to those in the study only and results are not generalizable.
4.3	HIV Risk-Related Behavior 
Of the six studies that focused on determining whether or not HIV risk-related behaviors were higher among SSEs, evidence suggests that the highest risk was among those who are secondary exchangers and have no direct contact with SEPs, also known as receptive exchangers. Although measurements and variables differed among the studies, it is clear that this subgroup of secondary syringe exchangers is at higher risk versus primary or “distributive” exchangers, who access SEPs directly and receive the benefits of the medical and social services provided.() 
Although several of the studies described engaging in SSE as a potential risk factor for blood borne pathogens, it is very important to describe the limitations of these findings. Five of the six studies were subject to both social desirability and recall bias. This could have a huge impact on the results of risk related behavior. This is further complicated by the fact that some of the studies surveyed participants about their injection behaviors in the past 6 months. In order to correct for these biases, further studies should question participants about injection drug-related behaviors in the past week and on more frequent occasions, using anonymous surveys to correct for social desirability and interviewer bias. 
In addition, five of the six studies were cross-sectional and, hence, unable to establish temporality and causality. ADDIN EN.CITE (, , , ) The same five studies also used convenience sampling and, therefore, generalizability is restricted. Convenience sampling affects any study because, as described by Latkin, members of the same social groups or drug networks display similar injection drug behaviors, undoubtedly, undermining the confidence in the results.(16) Also, study participants were not randomized into groups in any of the studies detailed in section. In addition, as described in Murphy et al., fear of exposure, illness, location of SEPs, and hours of operations of SEPs, are key barriers to SEP use.() Therefore, these studies could be excluding “receptive” exchangers, those who do not access the SEP directly, and who are of potentially highest risk.
As discussed previously, the definitions of secondary exchangers were very important to the results of the study and the varying concepts and classifications of SSEs meaning that comparison between the studies is difficult. The lack of specificity, with regard to whether or not the secondary exchanger has contact with the SEP directly, lowers the possibility of a causal relationship between SSE and higher HIV risk-related behaviors. For example, in the Social Context of Needle Selling in Baltimore, Maryland, Latkin et al. defined their study populations as either needle-sellers or non-sellers, excluding those who access SEPs but do not sell needles. ADDIN EN.CITE () Also, Sears et al. created an intervention site and comparison site to study the risk reduction of HIV-related behaviors.() However, there was frequent contact between the intervention site and comparison and the study did not clearly define the SSEs as distributive or receptive or both.() Therefore, in order to determine which aspects of this study were beneficial to the intervention group and whether SSE was protective for distributors, receptors, or both further studies should eliminate these biases.
Given the vast limitations of these studies, the results have indicated that attending an SEP for syringe exchange has a protective benefit with regards to HIV risk-related behavior for both categories of secondary exchangers versus those that do not participate in SSE. Although, it is clear that primary or “distributive” syringe exchangers are less likely to engage in HIV risk-related behaviors than secondary or “receptive” exchangers.() This could be due to what NIDA highlights, as well as all of the studies included in this review, as the most important factors of SEPs, access to HIV and hepatitis risk-related education through case management and materials.()
Therefore, the main objective of these programs should highlight the education of HIV and hepatitis risk-related behaviors in those who are distributing sterile syringes to those who do not access SEPs directly.() The benefits of the direct interaction with SEPs and the education received are evidenced by the measures of association in studies that compared distributive and receptive exchangers.() For example, two studies found that primary exchangers had lower odds to participate in needle sharing versus secondary exchangers. ADDIN EN.CITE (, ) Two studies showed that primary exchangers are more likely to bleach a needle after someone has used it and are more likely not to share cookers with other IDUs than both secondary and non-exchangers. ADDIN EN.CITE (, ) Secondary exchangers had higher odds of back loading, using someone else’s used cotton, and lending a used needle in one study.() In Shrestha et al., researchers found that out of all returned syringes, 52% of IDUs indicating primary exchange behaviors had evidence of MPU and 64% of secondary exchangers had evidence of MPU. ADDIN EN.CITE () 
Finally, two more of the studies (Huo et al. and Murphy et al.) showed that in comparison to secondary exchangers and non-exchangers, being a primary type of SSE was the most protective against HIV risk-related behaviors.(, ) Lorvick et al. went into further detail and described SSEs as reciprocal (gave and received needles), receptive (received only), and distributive (gave only).() Using no SSE activity as a reference group, researchers found that being a distributive SSE was associated with lower odds of needle sharing and being a receptive SSE had the highest odds of needle sharing.() An explanation for this higher risk could be the lack of HIV and hepatitis education that they would receive through accessing SEPs directly.  Primary or “distributive” exchangers could be used as a vehicle for HIV and hepatitis education in this population if the IDU is unwilling to attend an SEP. 
Sears et al. was the only study that suggested that SSE, with no differentiation between exchangers who had access to an SEP and those who did not, had a protective effect on participants. SSEs had lower odds of sharing a needle, reusing a syringe and cotton someone else had used, and engaging in sex without a condom. However, it is important to note that this was the only study that incorporated education, intervention techniques, and other activities to engage this specific population and thus is a likely explanation for these results.()
Secondary or receptive only, exchangers have higher odds of engaging in HIV risk-related behaviors compared to primary exchangers, as evidenced by the results of these studies. However, when compared to non-exchangers, secondary exchangers showed protective benefit through interaction with primary exchangers. Given the bias associated with all studies included in the literature review, further studies with better study design are needed to confirm consistency and coherence of these findings. 
4.4	Seroconversion
Valente et al. was the only study that focused on predicting seroconversion among their study participants in relation to SSE. The major strength of this study was that it was a prospective cohort and was able to establish temporality. However, there were many limitations to this study. It only focused on exchangers who distributed needles and not those who received. In addition, while the data was compelling for women SSEs, it is only suggestive and the cohort had twice as many men as women in the study. Women who returned needles acquired by someone else initially were more likely to become HIV positive than those who returned their own syringes.() 
Valente et al. showed that the use of SEPS, BNEP in particular, were the best protective measures against HIV seroconversion. However, the women who engaged in SSE were still accessing the BNEP; therefore, one would assume that they experienced the benefits of a SEP. An explanation for this could be linked back to previous discussion on drug networks. It is possible that women who exchange for themselves have lower odds of seroconversion due to smaller, closed networks of drug users. Women who engage in SSE may have larger networks and could be exchanging needles for a male partner (males relaying was not significantly associated with seroconversion), or acquired them from someone else in their drug network.() 
5.0 	cONCLUSION
The results of these studies should be used productively in public health, policy development, and they warrant further study. Although federal money designated for syringe exchange programs was not a large sum, only $2,700,000, the federal ban prevents approximately 2,783,505 sterile needles from entering circulation in intravenous drug using communities.() As mentioned, in New York State alone, SEPs distribute approximately 3 million needles annually.() The results of this study indicate that the federal ban on syringe exchange funding will have a devastating impact on public health as well as the advances in HIV prevention and that further research on secondary exchangers should be supported. 
As mentioned, only roughly 10% of injecting drug users currently access SEP services and this could decrease dramatically with the recent ban on federal funding.() In response to limited funding and access to services, the IDU community has spontaneously responded to its unmet needs through the emergence of secondary syringe exchanges. Also, it is extremely important to note that needle exchange protects not only IDUs, but also the community at large. Not only do the activities of SSEs prevent HIV, HCV, and HBV among intravenous drug users, they prevent secondary transmission among the sexual partners of IDUs and reduces incidence in children of IDUs by perinatal transmission.() This demonstrates the significance of SEPs as well as the impact that SSEs might have, and it is clear that expanded funding and access for IDUs could make meaningful strides in reducing HIV transmission. That being said, of the studies included in this literature review, none were able to provide adequate evidence of a causal relationship between SSEs, lower HIV incidence, and lower HIV-related risk behaviors. Therefore, the significance of the present investigation was to combine and compare the limited information on secondary exchange and provide suggestions for further studies.
Future studies should engage a variety of SSE users. Common characteristics of those engaged in SSE activities are male, African American, older, and unemployed. However, in the course of review, it became evident that certain groups were not included in the study designs. For example, there is no mention of men who have sex with men (MSM) or transsexual IDUs. The lack of inclusion of these or any specific groups has severe implications for validity. The sample is not representative and, therefore, results and/or interventions may not applicable to groups not included. The exclusion of receptive SSEs follows the same logic. Many of those included in studies were distributing SSEs only and were likely recruited because that subgroup of SSEs accesses SEP services. Inconsistencies of how and why injecting drug users engage in SSE are, in part, due to differing definitions of secondary exchange, satellite exchange, and relay exchange.() Therefore, future studies should attempt to engage demographically different SSEs and both distributive and receptive SSEs. 
Although several studies attempted to characterize the demographics, social interactions, and drug networks of those engaged in SSE activities, further qualitative research is needed. Focus groups would be especially useful to identify why and how IDUs engage in SSE and how SSEs differ from one another. Conducting focus groups among IDUs would give in-depth data about particular groups included and excluded from these studies and provide more detailed information that would be essential for the design of future longitudinal studies.   
Longitudinal studies, such as prospective cohort studies, would also provide more information on whether or not the HIV risk-related behaviors of SSEs are consistent, whether SSE activity leads to drug referral and treatment, whether SSE leads to seroconversion, and how secondary exchangers compare to those who do not participate in any exchanges. 
As cited in the majority of literature, educational modules are an essential component to any programs which involve SSEs. A major strategy that should be employed is peer-based education about prevention.() SSEs should be trained not only in risk reduction for HIV/AIDs but also in HCV and HBV. Most studies do not include HCV and HBV education. Participants in these studies are at high risk for HCV and HBV which is much more infectious than HIV via blood-to-blood contact due to the sharing of syringes and injection equipment.() In addition, SSEs could expand their roles as peer-educators and be trained in drug splitting techniques, vein and skin care, and overdose prevention. ADDIN EN.CITE (, ) Intervention studies, comparable to Sears et al. in design, are essential for identifying the implications of using SSE to expand the capacity of SEPs in the United States.(14) 
Future studies should attempt to investigate the importance of SSE networks further, especially in relation to distributive exchangers. That being said, receptive exchangers were found to be at highest risk for HIV-related risk behaviors, although, those who did not participate in SSE at all were at even higher risk, providing evidence of some protective benefit associated with SSE. Many SEPs require one-for-one exchanges thus limiting the amount of sterile equipment that can be disseminated to the IDU population through distributing exchangers. It would certainly seem that this population would benefit from lifting restrictions on this policy. Policies of SEPs and their relation to SSEs vary greatly between states. Further research is needed on policy with regard to funding, zoning, political ideologies, law enforcement activity and involvement as well as exchanging policy with regard to SEPs and the use of SSEs. 
The literature reviewed in this study, identified greater risk associated with being a receptive-only secondary exchanger, most likely because these clients have no interaction with SEPs and only receive sterile injection equipment through others. In addition, it revealed that when compared to those who do not exchange at all, primary exchangers have higher odds of avoiding HIV risk-related behaviors, perhaps due to their participation and education at SEPs. Although the majority of studies mitigates the risks of SSE, they do not completely eliminate the risk.() SSE extends the benefits of needle exchange to people that are unable or unwilling to access SEPs, at times beyond the capability of SEPs. Because these studies are not strictly comparable, it is impossible to extrapolate the results with great confidence, and further studies should be conducted on the effectiveness of SSE. 






TABLE 1. STUDY DESIGNS
Citation	Study DesignStudy Period	Setting	Source PopulationRecruitment Style	Outcomes Investigated
Huo et al. 	Cross-sectionalMarch 1997-July 2000	Store-front offices and motor-based office of one SEP in Chicago, Il	Males and females, older than 18 years of age with history of injecting in the past 6 months and with SEP use or no SEP useRecruitment took place at SEP, and recruitment for non-SEP using IDUs took place in the streets and through chain referral sampling	Risk behaviors associated with primary-only SEP users, mixed/secondary SEP users, and non-SEP users
Latkin et al. Social Context of Needle Selling in Baltimore, MD	Cross-sectionalFebruary 2001-September 2003	SEPs in Baltimore, Maryland, specifically, the Baltimore City Needle Exchange Program (BNEP)	Males and females 18 years of age or older, with consistent weekly contact with other drug users, willing to conduct HIV/AIDS outreach education, willing to connect 2 members within social network to the program, and not currently enrolled in other HIV prevention interventions or social network studiesData was collected as a part of SHIELD (Self-Help In Eliminating Life-threatening Disease) and participants were recruited through ethnographically guided outreach at SEPs and in areas of Baltimore with high levels of public drug use activity	Examined types and frequencies of social interactions among drug injectors who sell needles compared to individuals who do not sell needles
Latkin et al. Direct and Indirect Acquisition of Syringes from Syringe Exchange Programmes in Baltimore, Maryland, USA	Cross-sectionalApril 2000- November 2001	The Baltimore City Needle Exchange Program (BNEP) in Baltimore, Maryland	Males and females using BNEP and had injected drugs in the six months prior to the studyData was collected as a part of SHIELD (Self-Help In Eliminating Life-threatening Disease) and participants were recruited through targeted outreach areas with high levels of drug activity	Assessed the acquisition of needles from the BNEP as well as factors associated with obtaining syringes from BNEP. In addition, support and risk factor network variables were observed
Lorvick et al.	Cross-sectional2002	23 SEPs in 16 different California counties (Almadea, Contra Costa, Fresno, Humboldt, Los Angeles, Marin, Mendocino, Monterey, Sacramento, San Francisco, San Diego, San Mateo, Santa Barbara, Santa Clara, and Sonoma)	Males and females with injection drug use and SEP use in the past 30 daysRecruitment took place at the SEPs included in the study during normal operating hours	Determination of the secondary exchange effects of SEPs
Murphy et al.	Cross-sectional1992-September 2005 	SEP: San Francisco AIDS Prevention Project, 12 sites at 8 different locations in San Francisco, California	Males and females with injection drug use in the San Francisco Bay areaRecruitment involved maximum variation sampling at 12 sites of the San Francisco AIDS Prevention Project. Primary exchangers were then asked to recruit people who they exchanged for and non-exchangers were referred by both primary and secondary exchangers	Identified routes of syringe distribution, barriers for SSEs to accessing SEPs, and risk reduction comparison between primary and secondary exchangers
Riehman et al.	Cross-sectionalMay-December, 2001	23 SEPs in 14 different counties in California (not given)	Males and females with SEP and injecting drug use in the past 30 days and willingness to be tested for HIV	If SSE is protective against HIV
Sears et al.	Cross-sectionalJuly-September, 1997	Homeless camps in Golden Gate Park (intervention site) and Market Street in downtown (comparison site) in San Francisco, California	Homeless, young (15-25), males and females with injection drug use in the past 30 daysRecruitment took place at the SEP and in homeless camps of Golden Gate Park	Test an intervention method combining SSE and community-level activities
Shrestha et al.	Prospective CohortSeptember 1994-February 1997	Cohort from the AIDS Link to Intravenous Experience study (ALIVE) located in Baltimore, Maryland	Male and female IDUs that met requirements for ALIVE studyParticipants were recruited through (ALIVE)	Used 3 short tandem repeat (STR) genetic biomarkers to detect sharing in needles distributed with barcodes
Snead et al.	Descriptive, QualitativeCross-sectionalJune-December, 2000	SEPs: Alameda County Exchange (ACE) and Exchange Works in Oakland, North Richmond, and Richmond, California respectively	SSE recipients and distributors SSE providers were recruited from SEPs in three neighborhoods and asked to bring in recipients with monetary incentive	Why and how IDUs engage in SSE
Valente et al. Needle-Exchange Participation, Effectiveness, and Policy: Syringe Relay, Gender, and the Paradox of Public Health	Prospective cohortAugust 1994-February 1997	SEP: BNEP in Baltimore, Maryland	Males and females who visited BNEP within the 30 month study period Recruited at BNEP and given barcoded syringes	To determine the extent of which SEP use was associated with primary versus secondary exchange and how it was associated with syringe circulation














TABLE 2. STUDY RESULTS
Citation	Educational Component	Sample Size/ Screening UptakeConsent	Measures of Association or Significance	StrengthsLimitations
Huo et al.	No pre-test HIV counseling reportedNEP ancillary services and literature	901 drug injectors  enrolledPrimary-only NEP users: n=490Mixed/Secondary NEP users: n=224Non-SEP users: n=172~10% declined recruitment 15 excluded due to missing data for classificationWritten consent	Adjusted odds ratio of needle exchange type on Injection risk behaviors and drug treatment (primary-only vs. non-users and mixed/secondary vs. non-users)AOR (95% CI)Receptive needle sharingNon-SEP users: ReferentPrimary-only: 0.39(0.25-0.60)Mixed/Secondary: 0.53(0.32-0.86) Always Bleach used needlesNon-SEP users: ReferentPrimary-only: 2.50 (1.25-5.00)Mixed/Secondary: 2.94 (1.40-6.18)Back loadingNon-SEP users: ReferentPrimary-only: 0.38 (0.24-0.60)Mixed/Secondary: 0.63 (0.38-1.03)Share cookers, cotton, filter, waterNon-SEP users: ReferentPrimary-only: 0.49 (0.30-0.79)Mixed/Secondary: 0.74 (0.42-1.30)Lend used needleNon-SEP users: ReferentPrimary-only: 0.55 (0.36-0.84)Mixed/Secondary: 0.75 (0.46-1.21)Needle reuseNon-SEP users: ReferentPrimary-only: 0.18 (0.10-0.33)Mixed/Secondary: 0.22 (0.11-0.41)Drug TreatmentNon-SEP users: ReferentPrimary-only: 2.48 (1.65-3.74)Mixed/Secondary: 1.71 (1.07-2.71)	- Investigated “recipient only” exchangers- Sample size- Use of comparison group without previous SEP use- Sample has few “pure” secondary exchangers- Retrospective so no temporal relationship can be identified- Social desirability and recall bias- Primary only SEP users could inject alone versus mixed/secondary who may inject more frequently with others
Latkin et al. Social Context of Needle Selling in Baltimore, MD	Risk reduction and HIV/AIDS education	910 injectors enrolledAttrition rate of <15%n=253Needle sellers: n=56Non-sellers: n=197Informed consent obtained	Bivariate analysis of needle sellers and non-sellers on drug related interactions, HIV injection behaviors, and social network membershipGiving drugs to others or get drugs from othersNeedle sellers: 83.9%Non-sellers: 58.9%Using drugs with othersNeedle sellers: 85.7%Non-sellers: 57.4%Using a cooker that had been used by another personNeedle sellers: 69.6%Non-sellers: 54.3%Using a cotton that had been used by another personNeedle sellers: 64.3%Non-sellers: 44.7%Using rinse water after someone else had used itNeedle sellers: 50%Non-sellers: 32.5%Using needles/tools immediately after another person without bleaching it firstNeedle sellers: 25%Non-sellers: 11.2%Having others ask to use needlesNeedle sellers: 75%Non-sellers: 57.1%Number of different people you give a used or dirty needle to: at least 1 person vs. no oneNeedle sellers: 35.7%Non-sellers: 14.7%	- Social network descriptions- Educational component- Loss to follow-up- Social desirability, recall, and sampling bias- Proportion of needle selling may be higher than other cities due to higher volumes of IDUs, especially heroin injectors- Geographic location of SEPs- No data on non-injecting needle sellers
Latkin et al. Direct and Indirect Acquisition of Syringes from Syringe Exchange Programmes in Baltimore, Maryland, USA	No educational component reported	222 injectors enrolledRed/grey caps: n=84Other colors: n=138Informed consent obtained	Four variables associated with report of most recent cap as red/greyOR (95% CI)Obtain syringes from BNEP: 3.2 (1.7-5.9)Obtain syringes from spouse: 2.8 (1.0-7.6)Obtain syringes from friends/ neighbors: 2.6 (1.4-4.8)Number of drug users in network: 1.1 (1.0-1.3)Network characteristics by cap color of most recently used needleMeanNetwork sizeRed/Gray: 8.2Other colors: 7.4Number of drug users in networkRed/Gray: 3.4Other colors: 2.5Number of nets who are active usersRed/Gray: 2.4Other colors: 1.8Number of nets w/whom clients share cookersRed/Gray: 1.6Other colors: 1.0Number of nets w/whom clients share needlesRed/Gray: 0.5Other colors: 0.4Number of nets used unbleached needlesRed/Gray: 0.8Other colors: 0.4Number of nets who gave needles to client for the last 6 monthsRed/Gray: 0.7Other colors: 0.4Number of nets to whom client gave needles for the last six monthsRed/Gray: 1.0Other colors: 0.6	- Identification of network characteristics- Social desirability, recall, and sampling bias- Uncertainty that red/gray caps came from BNEP
Lorvick et al.	Respondents received risk reduction and HIV training	539 injectors enrolledSSE (distributing/receiving): n=406Non-SSE: n=133Verbal consent obtained at time of interview	Association between SSE and syringe sharing in logistic regressionAOR (95% CI)Syringe sharingReciprocal SSE (gave and received): 3.1 (1.61-5.33)Receptive SSE (received only): 4.1 (2.10-9.53)Distributive SSE (gave only): 1.2 (0.60-2.03)No SSE: Referent	- Identification of subgroups within SSE populations- Large sample size- Risk reduction education- All participants had at least some contact with SEPs- Participants were not randomly assigned- Response, social desirability, and recall bias- Cannot establish temporality
Murphy et al.	No educational component reported	224 injectors enrolledPrimary exchangers: n=82Secondary exchangers: n=82Non-exchangers: n=80Informed consent provided	Percent participating in syringe sharing risk behaviors by exchange statusIn the last 30 daysWent second with used syringePrimary: 20.7%Secondary: 25.6%Non-exchangers: 45.0%Shared cookerPrimary: 46.3%Secondary: 50.0%Non-exchangers: 65.0%Shared cottonPrimary: 45.1%Secondary: 47.6%Non-exchangers: 52.5%Used shooting galleryPrimary: 4.9%Secondary: 12.2%Non-exchangers: 13.8%Used old syringe to loadPrimary: 18.9%Secondary: 18.0%Non-exchangers: 40.6%Percent time cleaned skinPrimary: 85.2%Secondary: 76.8%Non-exchangers: 49.4%	- Identified secondary exchangers as those who receive not distribute- Selection, social desirability, and recall bias
Riehman et al.	HIV pretest counseling	531 SEP clients enrolledFemales: n=175Males: n=35655 not eligible due to non-use in the past 30 daysInformed consent provided	Logistic regression predicting secondary exchange for women and men (OR 95% CI) No being referent groupReuse syringesFemale: 0.56 (0.26-1.21)Male: 0.31 (0.18-0.54)Receptive syringe sharing last 30 daysFemale: 0.31 (0.97-1.01)Male: 1.42 (0.70-2.91)Distributive syringe sharing last 30 daysFemale: 4.14 (1.28-13.35)Male: 0.94 (0.47-1.89)Unsafe vaginal/anal sex last 30 daysFemale: 0.53 (0.18-1.56)Male: 0.77 (0.39-1.50)HIV-positive test resultFemale: 0.58 (0.08-4.22)Male: 0.26 (0.05-1.32)	- Gender specific study- Representative sample, proportional to amount of clients SEPs served- Large sample size- Selection, social desirability, and recall bias- Convenience sample (generalizability)- No refusal data- Twice as many male participants than female- Limited knowledge of drug-using social network members
Sears et al.	Four core peers at intervention site received training in SEP and HIV test counseling	122 injectors enrolled3 not eligible due to ageIntervention site: n=67Comparison site: n=55Verbal consent obtained at time of interview	Results  of multiple logistic regression indicating HIV risk behaviorAOR (95% CI)Nonintervention siteShare needle: 3.748 (1.406-9.988)Syringe reuse: 2.769 (1.120-6.847)Used someone’s cotton: NAInconsistent condom use with partner: 4.825 (1.392-16.721)	- First study to report enhanced benefits of SSE intervention and risk behaviors- Incorporated active involvement of subpopulation- Incorporated education and other sustainable components for marginalized population- Three established SEPs were located near intervention site- Data cannot extrapolate which of the intervention techniques are responsible for protective effects- Cannot establish temporal relationship- Participants were recruited using convenience sampling, therefore, not generalizable- Social desirability, recall, and response bias- No randomization of participants- Groups had frequent contact with each other
Shrestha et al.	On request, HIV testing with pre- and post-test counseling was available to participants. In addition, TB skin testing and referrals to subsidized drug treatment were available	5369 IDUs were dispensed bar-coded syringesRandom sample of 315 ALIVE  participants were selected and 2512 syringes were tested4 excluded due to high number of syringe exchangesInformed consent obtained	Percentage of syringes associated with Multiperson use (MPU)Primary exchangers: 52%Secondary exchangers: 64%Primary and Secondary: 28%Multivariate analysis indicating MPU is associated with several HIV risk factorsAOR (95% CI)**Restricted to primary exchangersNo being referent categorySharing cottonPrimary: 2.06 (1.30-3.28)Lending syringesPrimary: 1.70 (1.24-2.34)Injecting less than dailyPrimary: 0.64 (0.43-0.95)	- Prospective cohort- Additional ancillary education/ services provided to participants- Limited bias- Study assumed that individuals used the syringes they exchanged- Self-reports, used for validation, may not have represented the participants actual behavior- Did not perform multivariate analysis on secondary-only exchangers, or mixed, primary and secondary exchangers to obtain data on HIV risk factors
Snead et al.	No educational component	47 Injectors enrolledWritten consent	None	- Descriptive analysis of distributor and receptive SSE clients- Discussed peer education interventions other topics with participants to gage what the community needs- Small sample size- Only 20% of sample had never used an SEP prior to interview- Convenience sampling (generalizability)- Recall, selection, interviewer, and social desirability bias 
Valente et al. Needle-Exchange Participation, Effectiveness, and Policy: Syringe Relay, Gender, and the Paradox of Public Health	Educational component provided by SEP	5,369 injectors visited BNEP within the study periodParticipants were eliminated if:They only visited the SEP once (n=1,910)If they did not return any program needles (n=954)If sociodemographic information was missing (n=12)If they test positive for HIV (n=141)Final study sample: n=262Written consent obtained	Bivariate logistic regression for likelihood of seroconversion (n=262)OR (95% CI)Female: 1.49 (0.46-4.84)Age Categorized: 1.06 (0.88-1.19)Cohabit: 1.34 (0.41-4.34)Live in own residence:0.99(0.30-3.19)Frequency of drug use: 1.64 (0.68-3.98)Duration in study: 2.06 (1.24-3.42)BNEP use: 1.18 (0.65-2.15)Syringe relayer: 2.73 (0.85-8.76)Circulation time: 0.98 (0.93-1.02)Multivariate logistic regression for likelihood of seroconversionAOR (95% CI)Duration in study: 2.45 (1.36-4.42)Male, no relay (referent group): 1.00Male ,relay: 1.07 (0.19-3.22)Female, no relay: 0.36 (0.04-3.22)Female, relay: 8.53 (1.83-39.79)	- Prospective cohort- Use of barcoded needles- Data regarding HIV seroconversion are only suggestive- Almost twice as many males as females in study- Focused on relayers who distributed only, not received
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